Hepatitis E virus inhibits interferon-alpha signaling by preventing STAT1 phosphorylation, revealing a mechanism of viral immune evasion.
No takes yet. Share an insight, caveat, or question.
HEV may evade IFN-alpha via STAT1 blockade; leaves open whether pathway targeting merits clinical investigation in hepatitis E.
Chen et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: